AU5095996A - Interferon-gamma treatment of HLA-DR-associated immunodeficiency - Google Patents

Interferon-gamma treatment of HLA-DR-associated immunodeficiency

Info

Publication number
AU5095996A
AU5095996A AU50959/96A AU5095996A AU5095996A AU 5095996 A AU5095996 A AU 5095996A AU 50959/96 A AU50959/96 A AU 50959/96A AU 5095996 A AU5095996 A AU 5095996A AU 5095996 A AU5095996 A AU 5095996A
Authority
AU
Australia
Prior art keywords
hla
interferon
gamma treatment
associated immunodeficiency
immunodeficiency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50959/96A
Other languages
English (en)
Inventor
Given Not
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU5095996A publication Critical patent/AU5095996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU50959/96A 1994-10-22 1995-10-19 Interferon-gamma treatment of HLA-DR-associated immunodeficiency Abandoned AU5095996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4437868A DE4437868A1 (de) 1994-10-22 1994-10-22 Behandlung von HLA-DR-assoziierter Immundefizienz mit Interferon-gamma
DE4437868 1994-10-22
PCT/EP1995/004099 WO1996012500A1 (de) 1994-10-22 1995-10-19 BEHANDLUNG VON HLA-DR-ASSOZIIERTER IMMUNDEFIZIENZ MIT INTERFERON-$g(g)

Publications (1)

Publication Number Publication Date
AU5095996A true AU5095996A (en) 1996-05-15

Family

ID=6531496

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50959/96A Abandoned AU5095996A (en) 1994-10-22 1995-10-19 Interferon-gamma treatment of HLA-DR-associated immunodeficiency

Country Status (5)

Country Link
AU (1) AU5095996A (de)
CA (1) CA2203255A1 (de)
DE (1) DE4437868A1 (de)
WO (1) WO1996012500A1 (de)
ZA (1) ZA958950B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10218328A1 (de) * 2002-03-05 2003-09-25 Humboldt Uni Zu Berlin Medizin Mittel zur präventiven Therapie nach akutem Schlaganfall
DE102005053679A1 (de) * 2005-06-24 2006-12-28 Bayer Healthcare Ag Therapeutischer Einsatz von Moxifloxacin zur Rekonstruktion von Funktionsstörungen des Immunsystems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3829180A1 (de) * 1988-08-29 1990-03-08 Boehringer Ingelheim Int Neues arzneimittel zur vorbeugung und behandlung von durch primaere immundefekte verursachte krankheiten
US5198212A (en) * 1988-10-31 1993-03-30 University Of Lousville Research Foundation Incorporated Method and compositions for treatment of trauma-associated sepsis with gamma interferon

Also Published As

Publication number Publication date
CA2203255A1 (en) 1996-05-02
ZA958950B (en) 1996-04-22
DE4437868A1 (de) 1996-04-25
WO1996012500A1 (de) 1996-05-02

Similar Documents

Publication Publication Date Title
AU2041195A (en) Process of sterilization
AU7772794A (en) Treatment of obesity
AU1173195A (en) Treatment of immunoregulatory disorders
AU7973994A (en) Combination therapy for hiv infection
AUPM761094A0 (en) Treatment of hides
AU1115095A (en) Treatment of cellulose
AU1251197A (en) Treatment of liquors
ZA96722B (en) Combination therapy for hiv infection
AU3836489A (en) Treatment of immunodeficiency
AU4229197A (en) Treatment of equine protozoal myeloencephalitis
AU7565894A (en) Acupuncture treatment of common baldness
AU6829696A (en) Treatment of solutions
AU3530395A (en) Treatment of viral infections
AU4546096A (en) Treatment of waste
AU2547895A (en) Therapeutic phenoxyalkylheterocycles
AUPN221195A0 (en) Combined waste treatment
PL317876A1 (en) Combined treatment of hiv infections
AU5095996A (en) Interferon-gamma treatment of HLA-DR-associated immunodeficiency
AU7272094A (en) Preparation of electrode
AU4584293A (en) Tonic
AU5419894A (en) Dental treatment aid
AU3430795A (en) Treatment of fabrics
AU3874795A (en) Oral treatment
AU2671895A (en) Bisquinolines for the treatment of malaria
AU3247995A (en) Treatment of hides